Samples derived from LRRK-PD subjects showed a specificity of 40% (6 out of 15), while 3 of 16 (18.8%) of non-manifesting LRRK2 carriers showed a positive RT-QuIC signal response. Here, LRRK2 is linked to Parkinson disease.